Celaid Therapeutics raises $2.6M Series A+ led by Vertex Ventures.

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Celaid Therapeutics raises $2.6M Series A+ led by Vertex Ventures.</p><p>Celaid Therapeutics develops provider of a selective ex vivo hematopoietic stem cell expansion platform and related therapies.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>Celaid Therapeutics</td></tr><tr><th>Round</th><td>Series A+</td></tr><tr><th>Amount</th><td>$2.6M</td></tr><tr><th>Lead Investor</th><td>Vertex Ventures</td></tr></tbody></table>
</div>
</div>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Celaid Therapeutics raises <strong>$2.6M</strong> Series A+ led by Vertex <a href="/company/ventures/">Ventures</a>.</p>
<p>Celaid Therapeutics develops provider of a selective ex vivo hematopoietic stem cell expansion platform and related therapies.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Celaid Therapeutics</td>
</tr>
<tr>
<th>Round</th>
<td>Series A+</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$2.6M</strong></td>
</tr>
<tr>
<th>Lead Investor</th>
<td>Vertex <a href="/company/ventures/">Ventures</a>
</td>
</tr>
</tbody></table>
</div>
</div>
</div>


Celaid Therapeutics Raises $2.6M From Vertex Ventures

Celaid Therapeutics Raises $2.6M From Vertex Ventures | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Celaid Therapeutics raises <strong>$2.6M</strong> Series A+ led by Vertex <a href="/company/ventures/">Ventures</a>.</p>
<p>Celaid Therapeutics develops provider of a selective ex vivo hematopoietic stem cell expansion platform and related therapies.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Celaid Therapeutics</td>
</tr>
<tr>
<th>Round</th>
<td>Series A+</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$2.6M</strong></td>
</tr>
<tr>
<th>Lead Investor</th>
<td>Vertex <a href="/company/ventures/">Ventures</a>
</td>
</tr>
</tbody></table>
</div>
</div>
</div>

Celaid Therapeutics Raises $2.6M From Vertex Ventures

ABOUT THIS STORY

Inside 645 Ventures: The firm's approach to Contrarian Investing, AI, Fintech and Founder-First Bets

Darren Bechtel Bet Big on Construction Tech Before Anyone Cared

Daytona Raises $60M at $1B Valuation

Company	Celaid Therapeutics
Round	Series A+
Amount	$2.6M
Lead Investor	Vertex Ventures

Celaid Therapeutics Raises $2.6M From Vertex Ventures

ABOUT THIS STORY

More articles

Inside 645 Ventures: The firm's approach to Contrarian Investing, AI, Fintech and Founder-First Bets

Darren Bechtel Bet Big on Construction Tech Before Anyone Cared

Daytona Raises $60M at $1B Valuation